BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 31155641)

  • 1. Insulinoma-associated protein 1 controls nasopharyngeal carcinoma to radiotherapy by modulating cyclin D1-dependent DNA repair machinery.
    Song R; Wei X; Wang Y; Hu S; Ba Y; Xiao X; Zhang J
    Carcinogenesis; 2020 May; 41(3):326-333. PubMed ID: 31155641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc finger transcription factor INSM1 interrupts cyclin D1 and CDK4 binding and induces cell cycle arrest.
    Zhang T; Liu WD; Saunee NA; Breslin MB; Lan MS
    J Biol Chem; 2009 Feb; 284(9):5574-81. PubMed ID: 19124461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of cell cycle control proteins SHP‑1/2, p16, CDK4 and cyclin D1 in radioresistant nasopharyngeal carcinoma cells.
    Peng G; Cao RB; Li YH; Zou ZW; Huang J; Ding Q
    Mol Med Rep; 2014 Oct; 10(4):1709-16. PubMed ID: 25109634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-16 induction after CDK4 knockdown is mediated by c-Myc suppression and inhibits cell growth as well as sensitizes nasopharyngeal carcinoma cells to chemotherapy.
    Jiang Q; Zhang Y; Zhao M; Li Q; Chen R; Long X; Fang W; Liu Z
    Tumour Biol; 2016 Feb; 37(2):2425-33. PubMed ID: 26383521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INSM1 functions as a transcriptional repressor of the neuroD/beta2 gene through the recruitment of cyclin D1 and histone deacetylases.
    Liu WD; Wang HW; Muguira M; Breslin MB; Lan MS
    Biochem J; 2006 Jul; 397(1):169-77. PubMed ID: 16569215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of cyclin D1 and survivin expression with sensitivity to radiotherapy in patients with nasopharyngeal carcinoma.
    Fu SM; Xu MX; Lin SM; Liang Z; Cai JH
    Genet Mol Res; 2014 Feb; 13(2):3502-9. PubMed ID: 24615109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of Annexin A1 Enhances Radioresistance and Inhibits Apoptosis in Nasopharyngeal Carcinoma.
    Liao L; Yan WJ; Tian CM; Li MY; Tian YQ; Zeng GQ
    Technol Cancer Res Treat; 2018 Jan; 17():1533034617750309. PubMed ID: 29357787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis.
    Zhang W; Zeng Z; Zhou Y; Xiong W; Fan S; Xiao L; Huang D; Li Z; Li D; Wu M; Li X; Shen S; Wang R; Cao L; Tang K; Li G
    Acta Biochim Biophys Sin (Shanghai); 2009 May; 41(5):414-28. PubMed ID: 19430707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of annexin A3 promotes ionizing radiation-induced EGFR activation and nuclear translocation and confers radioresistance in nasopharyngeal carcinoma.
    Yang L; Lu P; Yang X; Li K; Chen X; Zhou Y; Qu S
    Exp Cell Res; 2022 Sep; 418(2):113292. PubMed ID: 35850266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ClC-3 Chloride Channel Proteins Regulate the Cell Cycle by Up-regulating cyclin D1-CDK4/6 through Suppressing p21/p27 Expression in Nasopharyngeal Carcinoma Cells.
    Ye D; Luo H; Lai Z; Zou L; Zhu L; Mao J; Jacob T; Ye W; Wang L; Chen L
    Sci Rep; 2016 Jul; 6():30276. PubMed ID: 27451945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RPA1 downregulation enhances nasopharyngeal cancer radiosensitivity via blocking RAD51 to the DNA damage site.
    Zhang Z; Huo H; Liao K; Wang Z; Gong Z; Li Y; Liu C; Hu G
    Exp Cell Res; 2018 Oct; 371(2):330-341. PubMed ID: 30144445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.
    Marampon F; Gravina G; Ju X; Vetuschi A; Sferra R; Casimiro M; Pompili S; Festuccia C; Colapietro A; Gaudio E; Di Cesare E; Tombolini V; Pestell RG
    Oncotarget; 2016 Feb; 7(5):5383-400. PubMed ID: 26689991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircRNA_000543 knockdown sensitizes nasopharyngeal carcinoma to irradiation by targeting miR-9/platelet-derived growth factor receptor B axis.
    Chen L; Zhou H; Guan Z
    Biochem Biophys Res Commun; 2019 May; 512(4):786-792. PubMed ID: 30928094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy.
    Chang L; Huang J; Wang K; Li J; Yan R; Zhu L; Ye J; Wu X; Zhuang S; Li D; Zhang G
    BMC Cancer; 2016 Mar; 16():190. PubMed ID: 26951044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cyclin D1 enhances sensitivity to radiotherapy and reverses epithelial to mesenchymal transition for esophageal cancer cells.
    Su H; Jin X; Shen L; Fang Y; Fei Z; Zhang X; Xie C; Chen X
    Tumour Biol; 2016 Apr; 37(4):5355-63. PubMed ID: 26561473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an INSM1-binding site in the insulin promoter: negative regulation of the insulin gene transcription.
    Wang HW; Muguira M; Liu WD; Zhang T; Chen C; Aucoin R; Breslin MB; Lan MS
    J Endocrinol; 2008 Jul; 198(1):29-39. PubMed ID: 18417529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the Numb/Notch signaling pathway increases radiation sensitivity in human nasopharyngeal carcinoma cells.
    Shen ED; Zeng Q
    Kaohsiung J Med Sci; 2019 Aug; 35(8):474-485. PubMed ID: 31271505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of β-Catenin Decreases the Radiosensitivity of Human Nasopharyngeal Carcinoma CNE-2 Cells.
    He H; Lin K; Su Y; Lin S; Zou C; Pan J; Zhou Y; Chen C
    Cell Physiol Biochem; 2018; 50(5):1929-1944. PubMed ID: 30396174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of prognostic biomarkers for response to radiotherapy by DNA microarray in nasopharyngeal carcinoma patients.
    Yang S; Chen J; Guo Y; Lin H; Zhang Z; Feng G; Hao Y; Cheng J; Liang P; Chen K; Wu H; Li Y
    Int J Oncol; 2012 May; 40(5):1590-600. PubMed ID: 22267178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.
    Jiang S; Zhao C; Yang X; Li X; Pan Q; Huang H; Wen X; Shan H; Li Q; Du Y; Zhao Y
    Int J Mol Med; 2016 Jul; 38(1):113-22. PubMed ID: 27247259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.